EGFR and breast carcinoma: A confrontation of two IHC definitions of basal breast cancers in a series of 3744 cases [30] revealed that the five-biomarker definition (ER, PR, ERBB2, CK5/6 and EGFR) had superior prognostic value than the TN one.